Literature DB >> 495794

Unipolar mania: a distinct clinical entity?

J Nurnberger, S P Roose, D L Dunner, R R Fieve.   

Abstract

Of the 241 lithium clinic patients at the New York State Psychiatric Institute with bipolar I affective disorder, 38 (15.7%) had never been hospitalized or somatically treated for depression. These "unipolar manic" patients had a significantly lower incidence of rapid cycling and suicide attempts than other bipolar I patients. No differences were found, however, in risk of illness in first-degree relatives. Lithium was an effective prophylactic agent in these patients. Some patients originally classified as "unipolar manic" were found to have depressive episodes with additional information and clinical observation. "Unipolar mania" appears to be a subgroup of bipolar I illness, but there are no data to support the hypothesis that it is a separate entity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 495794     DOI: 10.1176/ajp.136.11.1420

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  5 in total

Review 1.  Unipolar mania: a necessary diagnostic concept.

Authors:  Jules Angst; Christoffel Grobler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-01-29       Impact factor: 5.270

2.  Subsyndromal states in bipolar disorder.

Authors:  Dushad Ram; Daya Ram
Journal:  Indian J Psychiatry       Date:  2010-10       Impact factor: 1.759

3.  Unipolar Mania: A Particular Aspect of Bipolar Disorder in Tunisia.

Authors:  Badii Amamou; Wafa Chebbi; Myriam Allegue; Ahmed Mhalla; Ferid Zaafrane; Lotfi Gaha
Journal:  Clin Psychopharmacol Neurosci       Date:  2018-05-31       Impact factor: 2.582

Review 4.  Unipolar mania: recent updates and review of the literature.

Authors:  Shubham Mehta
Journal:  Psychiatry J       Date:  2014-04-30

5.  A neuroplastic deafferentation hypothesis for bipolar disorder.

Authors:  Jonathan Rogers; Jamie Mirams; Rashmi Patel
Journal:  Med Hypotheses       Date:  2015-09-28       Impact factor: 1.538

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.